San Francisco, California, July 18, 2017: TMR Research offer a comprehensive outlook of the global viral disease diagnosis market through its latest publication. The research report, titled “Viral Disease Diagnosis Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” sheds light on the strengths, weaknesses, opportunities, and threats guiding the trajectory of the overall market. Emergence of various viral disease has led to significant rise in the demand for viral disease diagnosis solutions. The growing concerns about repercussions of viral diseases has spiked the awareness and urgency of early detection.
In the recent years, the incidence of rabies, influenza, HIV-1, poliovirus, zika, sars, and enterovirus has resulted in an urgent need for timely disease diagnosis, control, and management. The rapid pace of technological advancements, ongoing clinical research, and ever-changing environmental conditions are also expected fuel the growth of the global viral disease diagnosis market. The various tests available in the global market are serodiagnostic tests, viral isolation tests, and specimen examination tests. The growing investments in clinical research has significantly improved the diagnostic tools used for identifying the viral diseases in recent years.
In terms of geography, the global viral disease diagnosis market is segmented into North America, Europe, Asia Pacific, and Rest of the World. While the developed region such as North America and Europe are expected to be the key contributors, the developing regions are also expected to stand out. High level of awareness, better medical facilities, supportive government policies, and growing health concerns in developed regions are expected to keep the regional markets at the forefront. On the other hand, the growing unmet medical needs, increasing investment of pharmaceutical companies, and changing healthcare infrastructure in developing countries is expected to make Asia Pacific a key regional market in the coming years. Rest of the World, such as Africa and the Middle East is also anticipated to offer lucrative opportunities to the global market.
Some of the leading players operating in the global viral disease diagnosis market are bioMerieux, Abbott Laboratories, Thermo Fischer Scientific, Cepheid, Roche Diagnostics, Becton Dickinson and Company, Novartis Diagnostics, Affymetrix, and Siemens AG. The research report provides a detailed analysis of the competitive landscape present in the global viral disease diagnosis market. It also highlights the threat from alternatives and substitutes as well as from new entrants. The publication offers a valuable insight into the business and marketing strategies, research and development plans, and expansion plans of the key players operating in the global market. Additionally, it also includes comments and recommendations from expert market leaders to give the readers a holistic overview of the market dynamics.